Good dose: Sino Biopharma in $100m debut
Sino Biopharmaceutical has made its syndicated loan debut, launching a $100m three year financing. Confidence is high that the deal will sail through, thanks to the group’s strong financials.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts